集団シフトモデルを用いたアロステル抑制剤と活性剤の合理的な設計:インビトロ検証と人工バイオセンサへの応用
Francesco Ricci1, Alexis Vallée-Bélisle, Alessandro Porchetta
1Dipartimento di Scienze e Tecnologie Chimiche, University of Rome, Tor Vergata, Via della Ricerca Scientifica, 00133 Rome, Italy.
Journal of the American Chemical Society
|August 29, 2012
まとめ
研究者は,アロステリック制御のための集団シフトメカニズムを使用してバイオセンサを再設計しました. この方法により,バイオセンサ標的の親和度およびダイナミックレンジの正確なチューニングが可能になり,新しいバイオテクノロジーを可能にします.
科学分野:
- バイオテクノロジー バイオテクノロジー
- 分子生物学は分子生物学である.
- バイオフィジックス 生物物理学
背景:
- 構造を切り替えるバイオセンサは,特定の分子の検出に不可欠です.
- アロステル調節によるバイオセンサ活動の制御は,重要な課題です.
- バイオセンサ調節のための既存の方法は,複雑で限定的である可能性があります.
研究 の 目的:
- バイオセンサのアロステリック制御のための集団シフトメカニズムの有用性を実証する.
- 遠隔アロステリック部位を分子ビーコンにエンジニアリングする.
- 分子ビーコンのターゲット親和感とダイナミックレンジを調節する.
主な方法:
- 集団のシフトメカニズムを利用して,アロステリックサイトを導入した.
- 核酸検出のための光学センサーであるエンジニアリングされた分子ビーコン.
- ディスタルアロステル部位に阻害剤と活性剤を適用した.
主要な成果:
- 分子ビーコンにディスタルアロステリックサイトを成功裏に導入しました.
- アロステリック抑制とバイオセンサの活性化が実証されています.
- ターゲットアフィニティとダイナミックレンジの合理的な調節を3桁の大きさで達成しました.
結論:
- 集団のシフトメカニズムは,バイオセンサのアロステリック調節のための汎用的なアプローチを提供します.
- この方法は",スマート"なバイオマテリアルと人工バイオテクノロジーの合理的な設計を容易にする.
- 導入されたアロステリック制御は,バイオセンサアプリケーションのユーティリティとダイナミックレンジを高めます.
関連する概念動画
Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Microbial Biosensors
Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...

